Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Kirkpatrick

Showing results (131-140 of 156) with videos related to

Pageof 16
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|April 6, 2011
A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastomaDavid A Reardon, Scott Turner, Katherine B Peters, et al.
Cancer Treatment Reviews|August 16, 2024
Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscapeMichael Weller, Jordi Remon, Stefan Rieken, et al.
Advances in Radiation Oncology|August 13, 2025
Clinical Parameters Associated With Intracranial Progression Burden Following an Initial Stereotactic Radiosurgery Course in a Multi-institutional Brain Metastases CohortChristina C Huang, David J Carpenter, Jim Leng, et al.
Neuro-Oncology Advances|January 7, 2026
Impact of systemic therapy after stereotactic radiosurgery in patients with limited brain-only metastasisJamiluddin J Qazi, Amanda E D Van Swearingen, David J Carpenter, et al.
Advances in Radiation Oncology|July 2, 2026
Impact of Radionecrosis and Local Recurrence on Overall Survival After Stereotactic Radiosurgery for Brain MetastasesJim X Leng, Muzamil Arshad, David J Carpenter, et al.
Cancers|November 11, 2022
Prognostic Model for Intracranial Progression after Stereotactic Radiosurgery: A Multicenter Validation StudyDavid J Carpenter, Brahma Natarajan, Muzamil Arshad, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2023
Long-Term Intracranial Outcomes With Combination Dual Immune-Checkpoint Blockade and Stereotactic Radiosurgery in Patients With Melanoma and Non-Small Cell Lung Cancer Brain MetastasesEugene J Vaios, Rachel F Shenker, Peter G Hendrickson, et al.
JAMA Network Open|April 9, 2025
Symptomatic Necrosis With Dual Immune-Checkpoint Inhibition and Radiosurgery for Brain MetastasesEugene J Vaios, Rachel F Shenker, Peter G Hendrickson, et al.
The Lancet. Oncology|November 27, 2025
Neurocognitive outcomes in patients with brain metastases: a systematic reviewTarek Bou Dargham, Sebastian F Winter, Kristen Batich, et al.
Neuro-Oncology Advances|July 7, 2022
Combination laser interstitial thermal therapy plus stereotactic radiotherapy increases time to progression for biopsy-proven recurrent brain metastasesMatthew M Grabowski, Ethan S Srinivasan, Eugene J Vaios, et al.
Pageof 16

Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
Journal of the National Comprehensive Cancer Network : JNCCN|April 6, 2011
A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastomaDavid A Reardon, Scott Turner, Katherine B Peters, et al.
Cancer Treatment Reviews|August 16, 2024
Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscapeMichael Weller, Jordi Remon, Stefan Rieken, et al.
Advances in Radiation Oncology|August 13, 2025
Clinical Parameters Associated With Intracranial Progression Burden Following an Initial Stereotactic Radiosurgery Course in a Multi-institutional Brain Metastases CohortChristina C Huang, David J Carpenter, Jim Leng, et al.
Neuro-Oncology Advances|January 7, 2026
Impact of systemic therapy after stereotactic radiosurgery in patients with limited brain-only metastasisJamiluddin J Qazi, Amanda E D Van Swearingen, David J Carpenter, et al.
Advances in Radiation Oncology|July 2, 2026
Impact of Radionecrosis and Local Recurrence on Overall Survival After Stereotactic Radiosurgery for Brain MetastasesJim X Leng, Muzamil Arshad, David J Carpenter, et al.
Cancers|November 11, 2022
Prognostic Model for Intracranial Progression after Stereotactic Radiosurgery: A Multicenter Validation StudyDavid J Carpenter, Brahma Natarajan, Muzamil Arshad, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2023
Long-Term Intracranial Outcomes With Combination Dual Immune-Checkpoint Blockade and Stereotactic Radiosurgery in Patients With Melanoma and Non-Small Cell Lung Cancer Brain MetastasesEugene J Vaios, Rachel F Shenker, Peter G Hendrickson, et al.
JAMA Network Open|April 9, 2025
Symptomatic Necrosis With Dual Immune-Checkpoint Inhibition and Radiosurgery for Brain MetastasesEugene J Vaios, Rachel F Shenker, Peter G Hendrickson, et al.
The Lancet. Oncology|November 27, 2025
Neurocognitive outcomes in patients with brain metastases: a systematic reviewTarek Bou Dargham, Sebastian F Winter, Kristen Batich, et al.
Neuro-Oncology Advances|July 7, 2022
Combination laser interstitial thermal therapy plus stereotactic radiotherapy increases time to progression for biopsy-proven recurrent brain metastasesMatthew M Grabowski, Ethan S Srinivasan, Eugene J Vaios, et al.
Pageof 16